NCT01876823
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Behavior, +17 more
- Locations
-
- New York State Psychiatric Institute New York, United States
Clinical trial condition
Alzheimer Disease
Explore clinical trials studying Alzheimer Disease. Study availability and eligibility vary by location and protocol.
2,958 public trials
523 recruiting studies
Alzheimer Disease trial results
NCT01348061
- Conditions
- Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +18 more
- Locations
-
- Parexel Glendale, California, United States
- Memory Enhancement Centers of America Inc. Eatontown, New Jersey, United States
- Worldwide Clinical Trials San Antonio, Texas, United States
NCT00933608
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- NYU School of Medicine, Dept. of Psychiatry, Center for Brain Health New York, United States
NCT02197884
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Merksem, Belgium
NCT01190800
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
- Locations
-
- Hôpital Louis Mourier Colombes, France
NCT02260700
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Merksem, Belgium
NCT01890343
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +13 more
- Locations
-
- Research Site Manchester, United Kingdom
Completed
Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type
NCT02249403
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified
Completed
Valproate in Dementia (VALID)
NCT00071721
- Conditions
- Aberrant Motor Behavior in Dementia, Alzheimer Disease, Behavior, +18 more
- Locations
-
- Sun Health Research Institute Sun City, Arizona, United States
- University of Arizona Tucson, Arizona, United States
- University of California, Irvine Irvine, California, United States
- University of California, ADRC, San Diego La Jolla, California, United States
Completed
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
NCT00440050
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- University of Alabama, Birmingham Birmingham, Alabama, United States
- Banner Alzheimer's Institute Phoenix, Arizona, United States
- Sun Health Research Institute/Arizona Consortium Sun City, Arizona, United States
- University of California Irvine Irvine, California, United States